Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MEETINGS - Technomic Publishing will hold the following seminars (US) March - April 1998:

This article was originally published in Clinica

Executive Summary

Technomic Publishing will hold two seminars in Boston on the science and technology of designing medical equipment. Designing Neurovascular Devices, on March 30-31, will discuss topics such as applying the principles of neurovascular anatomy and physiology to the design of medical devices; understanding how diseases and injuries affect the neurovascular system; and identifying the regulatory requirements that apply to neurovascular products. Designing Cardiovascular Devices, on April 1-3, will cover the latest advances in cardiovascular devices and current pharmacological and surgical interventions. Contact Technomic in the US for more details. Tel: +1 717 291 5609. Fax: +1 717 295 9637.

You may also be interested in...

IPO Year In Review: Record-Year Bodes Well For 2021, And For More SPACs

Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.

Abbott Capitalizes On Pandemic Testing Boom; Device Sales Stay Almost Flat

Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.

Agios’ Mitapivat Shows Improvement In Regularly Transfused PKD Patients

While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts